BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18765423)

  • 1. A meta-analysis on XRCC1 R399Q and R194W polymorphisms, smoking and bladder cancer risk.
    Lao T; Gu W; Huang Q
    Mutagenesis; 2008 Nov; 23(6):523-32. PubMed ID: 18765423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. XRCC1 genetic polymorphisms and bladder cancer susceptibility: a meta-analysis.
    Wang C; Sun Y; Han R
    Urology; 2008 Oct; 72(4):869-72. PubMed ID: 18336890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. XRCC1 polymorphism and lung cancer risk in relation to tobacco smoking.
    Schneider J; Classen V; Bernges U; Philipp M
    Int J Mol Med; 2005 Oct; 16(4):709-16. PubMed ID: 16142409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk.
    Patel AV; Calle EE; Pavluck AL; Feigelson HS; Thun MJ; Rodriguez C
    Breast Cancer Res; 2005; 7(6):R1168-73. PubMed ID: 16457697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms XRCC1-R399Q and XRCC3-T241M and the risk of breast cancer at the Ontario site of the Breast Cancer Family Registry.
    Figueiredo JC; Knight JA; Briollais L; Andrulis IL; Ozcelik H
    Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):583-91. PubMed ID: 15066923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer, a meta-analysis of the literatures.
    Saadat M; Ansari-Lari M
    Breast Cancer Res Treat; 2009 May; 115(1):137-44. PubMed ID: 18481169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms/haplotypes in DNA repair genes and smoking: a bladder cancer case-control study.
    Matullo G; Guarrera S; Sacerdote C; Polidoro S; Davico L; Gamberini S; Karagas M; Casetta G; Rolle L; Piazza A; Vineis P
    Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2569-78. PubMed ID: 16284380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. XRCC1 polymorphism and lung cancer risk.
    Schneider J; Classen V; Helmig S
    Expert Rev Mol Diagn; 2008 Nov; 8(6):761-80. PubMed ID: 18999926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk.
    Stern MC; Umbach DM; van Gils CH; Lunn RM; Taylor JA
    Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):125-31. PubMed ID: 11219769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in XPD exons 10 and 23 and bladder cancer risk.
    Schabath MB; Delclos GL; Grossman HB; Wang Y; Lerner SP; Chamberlain RM; Spitz MR; Wu X
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):878-84. PubMed ID: 15824159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms in the DNA repair genes XRCC1, APEX1, XRCC3 and NBS1, and the risk for lung cancer in never- and ever-smokers.
    Ryk C; Kumar R; Thirumaran RK; Hou SM
    Lung Cancer; 2006 Dec; 54(3):285-92. PubMed ID: 17034901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between X-ray repair cross complementing group 1 codon 399 and 194 polymorphisms and lung cancer risk: a meta-analysis.
    Wang Y; Yang H; Li H; Li L; Wang H; Liu C; Zheng Y
    Cancer Lett; 2009 Nov; 285(2):134-40. PubMed ID: 19481337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-order interactions among genetic polymorphisms in nucleotide excision repair pathway genes and smoking in modulating bladder cancer risk.
    Chen M; Kamat AM; Huang M; Grossman HB; Dinney CP; Lerner SP; Wu X; Gu J
    Carcinogenesis; 2007 Oct; 28(10):2160-5. PubMed ID: 17728339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No association of ERCC1 C8092A and T19007C polymorphisms to cancer risk: a meta-analysis.
    Li Y; Gu S; Wu Q; Li Y; Fu X; Mao Y; Huang Y; Xie Y
    Eur J Hum Genet; 2007 Sep; 15(9):967-73. PubMed ID: 17522621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA repair gene XRCC3 codon 241 polymorphism, its interaction with smoking and XRCC1 polymorphisms, and bladder cancer risk.
    Stern MC; Umbach DM; Lunn RM; Taylor JA
    Cancer Epidemiol Biomarkers Prev; 2002 Sep; 11(9):939-43. PubMed ID: 12223443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk: a meta-analysis.
    Li S; Peng Q; Chen Y; You J; Chen Z; Deng Y; Lao X; Wu H; Qin X; Zeng Z
    PLoS One; 2013; 8(9):e73448. PubMed ID: 24039945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA repair gene polymorphisms and bladder cancer susceptibility in a Turkish population.
    Karahalil B; Kocabas NA; Ozçelik T
    Anticancer Res; 2006; 26(6C):4955-8. PubMed ID: 17214369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A meta-analysis on XRCC1 and XRCC3 polymorphisms and colorectal cancer risk.
    Jiang Z; Li C; Xu Y; Cai S
    Int J Colorectal Dis; 2010 Feb; 25(2):169-80. PubMed ID: 19915856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. hOGG1 Ser326Cys and XRCC1 Arg399Gln polymorphisms associated with chronic obstructive pulmonary disease.
    Yang SF; Xu YJ; Xie JG; Zhang ZX
    Chin Med J (Engl); 2009 Apr; 122(8):960-6. PubMed ID: 19493423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased risk of oral leukoplakia and cancer among mixed tobacco users carrying XRCC1 variant haplotypes and cancer among smokers carrying two risk genotypes: one on each of two loci, GSTM3 and XRCC1 (Codon 280).
    Majumder M; Sikdar N; Paul RR; Roy B
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2106-12. PubMed ID: 16172217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.